标题
Notch3 Targeting: A Novel Weapon against Ovarian Cancer Stem Cells
作者
关键词
-
出版物
Stem Cells International
Volume 2019, Issue -, Pages 1-8
出版商
Hindawi Limited
发表日期
2019-01-07
DOI
10.1155/2019/6264931
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Neural stem cell quiescence and stemness are molecularly distinct outputs of the Notch3 signalling cascade in the vertebrate adult brain
- (2018) Emmanuel Than-Trong et al. DEVELOPMENT
- Notch signaling as a therapeutic target for acute lymphoblastic leukemia
- (2018) Diana Bellavia et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Identifying the Unique Role of Notch3 in Adult Neural Stem Cell Maintenance
- (2018) Joshua D. Rieskamp et al. JOURNAL OF NEUROSCIENCE
- Concise Review: Resistance to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer: The Role of Cancer Stem Cells
- (2018) Marzia Del Re et al. STEM CELLS
- NOTCH3 inactivation increases triple negative breast cancer sensitivity to gefitinib by promoting EGFR tyrosine dephosphorylation and its intracellular arrest
- (2018) Giulia Diluvio et al. Oncogenesis
- Cancer stem cell niche models and contribution by mesenchymal stroma/stem cells
- (2017) Catharina Melzer et al. Molecular Cancer
- Ovarian cancer stem cells: still an elusive entity?
- (2017) Michela Lupia et al. Molecular Cancer
- Antagonism of EGFR and Notch limits resistance to EGFR inhibitors and radiation by decreasing tumor-initiating cell frequency
- (2017) Shi Hu et al. Science Translational Medicine
- Correlation of ALDH1 and Notch3 Expression: Clinical implication in Ovarian Carcinomas
- (2017) Mi Joung Kim et al. Journal of Cancer
- The Crosstalk between Ovarian Cancer Stem Cell Niche and the Tumor Microenvironment
- (2017) Manuel Varas-Godoy et al. Stem Cells International
- Epidemiology of ovarian cancer: a review
- (2017) Reid Brett M. et al. Cancer Biology & Medicine
- Heterogeneity of Cancer Stem Cells: Rationale for Targeting the Stem Cell Niche
- (2016) Maximilian Boesch et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Protein Kinase Cι Drives a NOTCH3-dependent Stem-like Phenotype in Mutant KRAS Lung Adenocarcinoma
- (2016) Syed A. Ali et al. CANCER CELL
- Blockade of Notch3 inhibits the stem-like property and is associated with ALDH1A1 and CD44 via autophagy in non-small lung cancer
- (2016) YUANYUAN MA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Cancer stem cell signaling pathways
- (2016) William H. Matsui MEDICINE
- Prolyl-isomerase Pin1 controls Notch3 protein expression and regulates T-ALL progression
- (2016) G Franciosa et al. ONCOGENE
- Targeting epithelial-mesenchymal transition and cancer stem cells for chemoresistant ovarian cancer
- (2016) Junli Deng et al. Oncotarget
- Ovarian cancer
- (2016) Ursula A. Matulonis et al. Nature Reviews Disease Primers
- The Cancer Stem Cell Niche: How Essential Is the Niche in Regulating Stemness of Tumor Cells?
- (2015) Vicki Plaks et al. Cell Stem Cell
- Notch3-specific inhibition using siRNA knockdown or GSI sensitizes paclitaxel-resistant ovarian cancer cells
- (2015) Haeyoun Kang et al. MOLECULAR CARCINOGENESIS
- The side population of ovarian cancer cells defines a heterogeneous compartment exhibiting stem cell characteristics
- (2015) Maximilian Boesch et al. Oncotarget
- EGFR Blockade Enriches for Lung Cancer Stem-like Cells through Notch3-Dependent Signaling
- (2014) R. R. Arasada et al. CANCER RESEARCH
- The Molecular Basis of Notch Signaling Regulation: A Complex Simplicity
- (2014) R. Palermo et al. CURRENT MOLECULAR MEDICINE
- Dedifferentiation and reprogramming: origins of cancer stem cells
- (2014) D. Friedmann-Morvinski et al. EMBO REPORTS
- Tackling the cancer stem cells — what challenges do they pose?
- (2014) Diwakar R. Pattabiraman et al. NATURE REVIEWS DRUG DISCOVERY
- Investigating Molecular Profiles of Ovarian Cancer: An Update on Cancer Stem Cells
- (2014) Federica Tomao et al. Journal of Cancer
- Notch Pathway Activity Identifies Cells with Cancer Stem Cell-like Properties and Correlates with Worse Survival in Lung Adenocarcinoma
- (2013) K. A. Hassan et al. CLINICAL CANCER RESEARCH
- Prolyl-isomerase Pin1 controls normal and cancer stem cells of the breast
- (2013) Alessandra Rustighi et al. EMBO Molecular Medicine
- Notch inhibitors for cancer treatment
- (2013) Ingrid Espinoza et al. PHARMACOLOGY & THERAPEUTICS
- Targeting Notch signaling pathway in cancer: Clinical development advances and challenges
- (2013) Naoko Takebe et al. PHARMACOLOGY & THERAPEUTICS
- Ovarian Cancer Stem Cells Are Enriched in Side Population and Aldehyde Dehydrogenase Bright Overlapping Population
- (2013) Kazuyo Yasuda et al. PLoS One
- MicroRNAs overexpressed in ovarian ALDH1-positive cells are associated with chemoresistance
- (2013) Young Tae Park et al. Journal of Ovarian Research
- Notch3 Overexpression as Potential Therapeutic Target in Advanced Stage Chemoresistant Ovarian Cancer
- (2012) Mohammed Tanjimur Rahman et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Cancer Stem Cells: Distinct Entities or Dynamically Regulated Phenotypes?
- (2012) Y. Li et al. CANCER RESEARCH
- Targeting Notch, a key pathway for ovarian cancer stem cells, sensitizes tumors to platinum therapy
- (2012) S. M. McAuliffe et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Identification of inhibitors of ovarian cancer stem-like cells by high-throughput screening
- (2012) Roman Mezencev et al. Journal of Ovarian Research
- Aldehyde Dehydrogenase in Combination with CD133 Defines Angiogenic Ovarian Cancer Stem Cells That Portend Poor Patient Survival
- (2011) I. A. Silva et al. CANCER RESEARCH
- Cancer Stem Cell Niche: The Place to Be
- (2011) T. Borovski et al. CANCER RESEARCH
- Stem Cell Pathways Contribute to Clinical Chemoresistance in Ovarian Cancer
- (2011) A. D. Steg et al. CLINICAL CANCER RESEARCH
- Side population is increased in paclitaxel-resistant ovarian cancer cell lines regardless of resistance to cisplatin
- (2011) Yoichi Kobayashi et al. GYNECOLOGIC ONCOLOGY
- The biological characteristics of glioma stem cells in human glioma cell line SHG44
- (2011) Li-Ye Yang Molecular Medicine Reports
- Cells of origin in cancer
- (2011) Jane E. Visvader NATURE
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- Notch3 Overexpression Is Related to the Recurrence of Ovarian Cancer and Confers Resistance to Carboplatin
- (2010) Joon Tae Park et al. AMERICAN JOURNAL OF PATHOLOGY
- Ovarian cancer stem-like side-population cells are tumourigenic and chemoresistant
- (2010) L Hu et al. BRITISH JOURNAL OF CANCER
- Aldehyde Dehydrogenase Activity Selects for Lung Adenocarcinoma Stem Cells Dependent on Notch Signaling
- (2010) J. P. Sullivan et al. CANCER RESEARCH
- Prognostic significance of Notch 3 gene expression in ovarian serous carcinoma
- (2010) Sang G. Jung et al. CANCER SCIENCE
- CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cells
- (2010) M-Q Gao et al. ONCOGENE
- Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
- (2009) Piyush B. Gupta et al. CELL
- Notch3 and pTα/pre-TCR sustain the in vivo function of naturally occurring regulatory T cells
- (2009) Antonio F. Campese et al. INTERNATIONAL IMMUNOLOGY
- Looking ahead in cancer stem cell research
- (2009) John E Dick NATURE BIOTECHNOLOGY
- Differential subcellular localization regulates c-Cbl E3 ligase activity upon Notch3 protein in T-cell leukemia
- (2009) S Checquolo et al. ONCOGENE
- Notch Pathway Blockade Depletes CD133-Positive Glioblastoma Cells and Inhibits Growth of Tumor Neurospheres and Xenografts
- (2009) Xing Fan et al. STEM CELLS
- Emerging role of Notch in stem cells and cancer
- (2008) Zhiwei Wang et al. CANCER LETTERS
- Identification and Characterization of Ovarian Cancer-Initiating Cells from Primary Human Tumors
- (2008) S. Zhang et al. CANCER RESEARCH
- Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells
- (2008) T Baba et al. ONCOGENE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started